Boston-based Moderna has been the S&P 500’s most shorted stock since the end of September, according to S3 Partners. Short ...

Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business ...

Moderna’s stock has seen a notable shift in sentiment after its fair value estimate was cut from $40.30 to $37.32. This ...

The first was a one-time stock option exchange program for non-Executive Committee employees, which received significant support from stockholders. The second proposal allowed for the adjournment of ...

Moderna ( ($MRNA) ) just unveiled an update. On November 19, 2025, Moderna, Inc. entered into a Credit and Guaranty Agreement providing a $1.5 ...

Moderna MRNA is set to report third-quarter 2025 earnings on Nov. 6, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $860 million and a loss of $2.15 per ...

On November 20, 2025, Moderna, Inc. announced updates on its pipeline progress and business strategy during its Analyst Day. This announcement is significant as it reflects the company’s ongoing ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BeOne Medicines (ONC – Research Report), Moderna (MRNA – Research Report) and ...

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

With the greater part of third quarter earnings results in the rearview mirror, investors are looking ahead to marquee ...